MEDICA 2025: Unique diagnostics of sepsis and the ultimate RNase inhibitor

We are going to participate in MEDICA 2025, the world’s leading trade fair for the medical industry, held in Düsseldorf, Germany. Our stand will be filled with a variety of biotech solutions, from molecular diagnostics of sepsis to custom monoclonal antibody development. Join us there to learn more about our portfolio.

One of the key projects we will present is our Ultrasensitive Sepsis Diagnostics. Sepsis remains one of the main causes of death worldwide, and fast, sensitive diagnostics is one of the key ways to address this challenge. That’s exactly why we are developing PCR-based tests that are significantly more sensitive and faster than common methods.

See: DIANA Biotechnologies: Ultrasensitive Sepsis Diagnostics

Another important part of our portfolio is our reagents for PCR and RT-PCR. We have introduced many new developments this year. Not only do we have a brand new generation of PCR and RT-PCR mixes, but the biggest innovation comes from RNA inhibition. Our protein facility, together with the PCR chemistry team, synthesized the ultimate RNase inhibitor. The DB Ultima H! We are setting a new standard for RNase inhibition with complete oxidative resistance, storage stability, and thermostability. Need proof? See the results here: DB Ultima H RNase Inhibitor: The ultimate RNase inhibitor

And remember: Your RNA didn’t fail. Your inhibitor did.

At our booth, visitors will have the opportunity to explore the full DIANA Biotechnologies portfolio, including our custom development of monoclonal antibodies. Our proprietary DIANA-Ab technology offers a solution to find and select the best possible clones for antibody development. Thanks to this, you’ll be able to detect even the smallest targets! Learn more here: https://www.dianabiotech.com/segment/monoclonal-antibodies

DIANA-Ab is not the only proprietary technology we have. The original DIANA, published by our CEO Václav Navrátil, is ideal for inhibitor discovery and profiling. We will also present several kinase profiling panels, together with a unique carbonic anhydrase panel.

We are looking forward to seeing you all! Our team will be on-site to present our innovative solutions, discuss new collaborations, and share insights into how DIANA Biotechnologies continues to push the boundaries of precision diagnostics.

Let’s meet at MEDICA 2025!